Live Cell Encapsulation Market Size To Reach USD 350 Million By 2028 Says Reports And Data

The global live cell encapsulation market size is expected to reach USD 350 million by 2028 and register a CAGR of 3.6%, according to the latest report by Reports and Data. Factors driving global market revenue growth are rising prevalence of target diseases and latest technological advancements in cell encapsulation techniques.

Live cell encapsulation is one of the most convincing approaches for treating various target diseases. It is a technology that encloses live cells in protective capsules that are equal to size of a headpin. Essential nutrients and blood are allowed to flow through the capsules in order to provide nourishment to the living cell. Capsule acts as a protective barrier to protect the cells from patient’s immune system. Market growth is driven by factors, such as increasing awareness regarding significance of using live cell encapsulation for treating target diseases and rising investments by market players to develop new products and techniques and enhance their product line.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4018

Unavailability of good quality raw materials, unaffordable prices for manufacturing of products, and accessibility to affordable alternative therapies are some key restraints expected to impede growth of the live cell encapsulation market. Moreover, lack of trained professionals for operating these modern techniques is expected to limit market growth during the forecast period.

Top Key Players:

BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) are the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US).

Some key highlights in the report:

In context to manufacturing techniques, the electrostatic dripping segment dominated other manufacturing techniques segments in 2020 and is expected to account for considerable market share during the forecast period. Growing implementation of electrostatic dripping technique in droplet generation and beneficial properties, such as cell viability retention and uniform size distribution, are some of the key factors boosting revenue growth.
Based on polymer type, the HEMA-MMA segment is expected to expand at a considerable CAGR during the forecast period owing to its use in diabetic management procedures and liver transplant techniques.
On the basis of application, the regenerative medicine segment is projected to be the fastest-growing segment between 2021 and 2028, which is attributable to growing trend of encapsulation in tissue engineering.
North America is expected to account for largest revenue share in the global live cell encapsulation market throughout the forecast period. Factors, such as growing healthcare expenditure, availability of advanced technologies, and increasing adoption of live cell encapsulation techniques, are augmenting market growth in this region.
The market in Asia Pacific is expected to register fastest CAGR of 3.4% over the forecast period. Rising prevalence of chronic disorders have increased demand for advanced techniques such as live cell encapsulation in this region.

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4018

For this study, Reports and Data has segmented the global live cell encapsulation market based on Manufacturing Technique, Polymer Type, Application, and Region:

Based On Manufacturing Technique (Revenue, USD Million, 2018 - 2028)

Simple Dripping
Electrostatic Dripping
Liquid Jet Break Up
Coaxial Airflow
Vibrating Jet
Jet Cutting
Rotating Disk Atomization

Based On Polymer Type (Revenue, USD Million, 2018 - 2028)

Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other Polymers

Based On Application (Revenue, USD Million, 2018 - 2028)

Drug Delivery
Regenerative medicine
Cell Transplantation
Probiotics
Research

Based On Region: (Revenue, USD Million, 2018 - 2028)

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Rest Of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Rest of MEA

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/4018

Explore Reports and Data's Prime Analysis of the global Pharma and Healthcare:

Hematologic Malignancies Market: https://www.reportsanddata.com/report-detail/hematologic-malignancies-market

Disruptive Behavior Disorder Treatment Market: https://www.reportsanddata.com/report-detail/disruptive-behavior-disorder-treatment-market

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs

Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.